Antibody
Detection method for COVID-19 and vaccine development progress
04-09-2020 / Dr. Edward Wong, Field Application Scientist, GenScript
Detection method for COVID-19 and vaccine development progress
Learn More
Gene
COVID-19 and emerging bat zoonotic viruses (EBZV) in a quarter of century
04-02-2020 / Linfa Wang, PhD, FTSE
COVID-19 and emerging bat zoonotic viruses (EBZV) in a quarter of century webinar.
Learn More Antibody
Using Structural Biology to Design New Vaccines
11-20-2018 / Dr. Guillaume Stewart-Jones, Senior Research Scientist, VRC, NIAID, National Institutes of Health
Vaccines are the most cost-effective and widespread medical intervention that has prevented human illness.
Learn More Gene
The Promise of AAV-Mediated Antibody Delivery for the Prevention and Treatment of HIV Infection
06-19-2018 / Sebastian P. Fuchs, Ph.D.
More than 35 years have passed since the first reported cases of AIDS and the discovery of HIV, and despite tremendous efforts no vaccine has been developed that could effectively protect against HIV infection in the vast majority of people.
Learn More Antibody
Characterization of the host antibody responses against anti-HIV/SIV antibodies delivered with AAV
06-26-2017 / Keshav
Long-term delivery of neutralizing antibodies by means of recombinant adeno-associated virus (rAAV) is a novel and promising approach for the prevention
Learn More Protein
Development of a Potential Recombinant Protein Vaccine in E. Coli
08-27-2016 / Keshav
Recombinant proteins can be powerful stimulators of the immune system making them good candidates for vaccines.
Learn More